跳到主要內容區塊
:::
開啟
2026/5/4 下午 05:18:43
:::
  • 20260514-1
  • 演講或講座
  • 生物醫學科學研究所
  • 地點

    生醫所地下室B1B演講廳

  • 演講人姓名

    朱雪萍 博士 (台大)

  • 活動狀態

    確定

  • 活動網址
RNA and chromatin: TERRA in Epigenetics and Human Disease

2026-05-14 14:00 - 15:00

加入行事曆

My research focuses on uncovering the roles and regulatory mechanisms of long non-coding RNAs (lncRNAs), particularly TERRA (Telomeric repeat-containing RNA), in epigenetic regulation, genome stability, chromatin dynamics, and telomere maintenance. I developed RNA-centric technologies—including CHIRT for mapping TERRA binding sites and iDRiP-MS for identifying RNA-binding proteins—to dissect the TERRA interactome and its genome-wide functions (Chu et al., Cell, 2017). This work revealed the role of TERRA in telomere protection, chromatin organization, and gene regulation. My lab further demonstrated that TERRA modulates DNA G-quadruplex structures and antagonizes chromatin remodeler ATRX at transcription start sites (Tsai et al., NAR, 2022), unveiling an RNA-based mechanism for epigenetic regulation. We also elucidated how TERRA contributes to Alternative Lengthening of Telomeres (ALT) in cancer by forming R-loops that recruit DNA repair proteins like XPF to initiate telomere synthesis (Guh et al., Nat Commun, 2022). Recently, we applied nanopore direct RNA-seq to characterize the TERRA transcriptome in human tissues, revealing increased TERRA levels during aging and early Alzheimer’s disease, suggesting TERRA as a potential biomarker for age-related disorders (Hsieh et al., NAR, 2025). Collectively, our research bridges RNA biology, telomere dynamics, and genome integrity, offering novel insights into non-coding RNA functions in both chromatin regulation and disease. In this talk, I will present our recent findings on how TERRA is involved in epigenetic regulation, aging, and human diseases.

回頂端